(Q34119645)

31 July 2017

1 reference

title

Natural killer cells, viruses and cancer (English)

1 reference

31 July 2017

Cerwenka A

1

1 reference

PubMed ID

11905813

31 July 2017

Lanier LL

series ordinal

2

1 reference

31 July 2017

1 October 2001

1 reference

Nature Reviews Immunology

31 July 2017

1 reference

31 July 2017

1

1 reference

31 July 2017

41-49

1 reference

31 July 2017

1

1 reference

Biology of natural killer cells

31 July 2017

1 reference

7 January 2021

A fresh look at tumor immunosurveillance and immunotherapy.

1 reference

7 January 2021

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

1 reference

7 January 2021

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

1 reference

7 January 2021

Regulation of immune responses through inhibitory receptors

1 reference

7 January 2021

Immune inhibitory receptors

1 reference

7 January 2021

Natural killer susceptibility is independent of HLA class I antigen expression on cell lines obtained from human solid tumors.

1 reference

7 January 2021

Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type

1 reference

7 January 2021

On guard--activating NK cell receptors

1 reference

7 January 2021

Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells

1 reference

7 January 2021

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells

1 reference

7 January 2021

Combined natural killer cell and dendritic cell functional deficiency in KARAP/DAP12 loss-of-function mutant mice.

1 reference

7 January 2021

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis

1 reference

7 January 2021

Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity

1 reference

7 January 2021

NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells

1 reference

7 January 2021

NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily

1 reference

7 January 2021

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

1 reference

7 January 2021

Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis.

1 reference

7 January 2021

DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells

1 reference

7 January 2021

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

7 January 2021

An activating immunoreceptor complex formed by NKG2D and DAP10

1 reference

7 January 2021

DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells

1 reference

7 January 2021

DAP12 and KAP10 (DAP10)-novel transmembrane adapter proteins of the CD3zeta family

1 reference

7 January 2021

Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA

1 reference

7 January 2021

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium

1 reference

7 January 2021

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

1 reference

7 January 2021

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

1 reference

7 January 2021

Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: one of the early inducible clones encodes a novel protein sharing several highly homologous regions with a Drosophila polyhomeotic protein

1 reference

7 January 2021

Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others

1 reference

7 January 2021

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

1 reference

7 January 2021

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

1 reference

7 January 2021

Arousal and inhibition of human NK cells

1 reference

7 January 2021

Severe herpesvirus infections in an adolescent without natural killer cells

1 reference

7 January 2021

Natural killer cells in antiviral defense: function and regulation by innate cytokines

1 reference

7 January 2021

Viral subversion of the immune system

1 reference

7 January 2021

Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog

1 reference

7 January 2021

Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein.

1 reference

7 January 2021

Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens.

1 reference

7 January 2021

The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides.

1 reference

7 January 2021

Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.

1 reference

7 January 2021

m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection

1 reference

7 January 2021

A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules

1 reference

7 January 2021

Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog.

1 reference

7 January 2021

The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.

1 reference

7 January 2021

The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells

1 reference

7 January 2021

Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors

1 reference

7 January 2021

Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells

1 reference

7 January 2021

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

1 reference

7 January 2021

Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays

1 reference

7 January 2021

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

7 January 2021

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

1 reference

7 January 2021

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9

1 reference

7 January 2021

Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family

1 reference

7 January 2021

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

1 reference

7 January 2021

Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo

1 reference

7 January 2021

Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function

1 reference

7 January 2021

Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen

1 reference

7 January 2021

Vital involvement of a natural killer cell activation receptor in resistance to viral infection.

1 reference

7 January 2021

Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H.

1 reference

7 January 2021

Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype

1 reference

7 January 2021

Cutting edge: a NK complex-linked locus governs acute versus latent herpes simplex virus infection of neurons

1 reference

7 January 2021

DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming

1 reference

7 January 2021

Identification of a human member of the Ly-49 multigene family

1 reference

7 January 2021

The human Ly-49L gene

1 reference

7 January 2021

Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.

1 reference

7 January 2021

Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia

1 reference

7 January 2021

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

1 reference

7 January 2021

Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis

1 reference

7 January 2021

Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins

1 reference

7 January 2021

A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation

1 reference

7 January 2021

Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein

1 reference

7 January 2021

Activating interactions in human NK cell recognition: the role of 2B4-CD48

1 reference

7 January 2021

Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4

1 reference

7 January 2021

2B4 functions as a co-receptor in human NK cell activation

1 reference

7 January 2021

2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48

1 reference

7 January 2021

Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48

1 reference

7 January 2021

The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM

1 reference

7 January 2021

Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome

1 reference

7 January 2021

Cutting Edge: Defective NK Cell Activation in X-Linked Lymphoproliferative Disease

1 reference

7 January 2021

Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity

1 reference

7 January 2021

X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells

1 reference

7 January 2021

Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP

1 reference

7 January 2021

NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease

1 reference

7 January 2021

Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin

1 reference

7 January 2021

Identifiers

DOI

10.1038/35095564

1 reference

31 July 2017

1 reference

PubMed ID

11905813